Skip to contentC
Cumberland Pharmaceuticals Inc
C
CPIXCumberland Pharmaceuticals Inc Q1 2015 · 10-Q
Revenue$8.69M$8.69M+7.3% vs Q1 2014 Net Income$46.28K$46.28K−83.8% vs Q1 2014 EPS Diluted$0.00$0.00−100.0% vs Q1 2014 Operating Income$4,116−99.0% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cumberland Pharmaceuticals Inc · CIK 1087294 · Engraved from SEC EDGAR
Free Cash Flowderived$1,925,163+102.1% Margins · derivedOperating margin0.0%−5.0 pt vs Q1 2014
Net margin0.5%−3.0 pt vs Q1 2014
ended Mar 31, 2015 · filed May 15, 2015 · 45 d after period end